Skip to main content

Table 2 Therapy regime and treatment duration

From: Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

  GT 1 GT 2 GT 3 GT 4
SOF + PEG + RBV     
 12 weeks 43 % (51) 0 12 % (14) 3 % (4)
 24 weeks 10 % (12) 0 0 0
SOF + RBV     
 12 weeks 0 12 % (14) 0 0
 24 weeks 11 % (13) 0 8 % (10) 1 % (1)
  1. Data are expressed as percent (number)
  2. GT genotype, SOF sofosbuvir, PEG pegylated-interferon, RBV ribavirin